These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32341133)

  • 41. A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy).
    Descamps OS; Van Caenegem O; Hermans MP; Balligand JL; Beauloye C; Bondue A; Carlier S; Castermans E; Chenot F; Claeys M; De Block C; de Leener A; De Meester A; Demeure F; De Raedt H; Desmet W; Elegeert I; Guillaume M; Hoffer E; Kacenelenbogen R; Lancellotti P; Langlois M; Leone A; Mertens A; Paquot N; Vanakker O; Vanoverschelde JL; Verhaegen A; Vermeersch P; Wallemacq C; Rietzschel E;
    Atherosclerosis; 2018 Oct; 277():369-376. PubMed ID: 30270073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcriptomic biomarkers of cardiovascular disease.
    Pedrotty DM; Morley MP; Cappola TP
    Prog Cardiovasc Dis; 2012; 55(1):64-9. PubMed ID: 22824111
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Precision Medicine.
    Loscalzo J
    Circ Res; 2019 Mar; 124(7):987-989. PubMed ID: 30920923
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical genomic testing: getting it right.
    Douglas PS; Ginsburg GS
    J Cardiovasc Transl Res; 2008 Mar; 1(1):17-20. PubMed ID: 20559953
    [No Abstract]   [Full Text] [Related]  

  • 45. Genetic testing in cardiovascular disease.
    Robin NH; Tabereaux PB; Benza R; Korf BR
    J Am Coll Cardiol; 2007 Aug; 50(8):727-37. PubMed ID: 17707176
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic cardiovascular risk prediction: will we get there?
    Thanassoulis G; Vasan RS
    Circulation; 2010 Nov; 122(22):2323-34. PubMed ID: 21147729
    [No Abstract]   [Full Text] [Related]  

  • 47. Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?
    Vrablik M; Dlouha D; Todorovova V; Stefler D; Hubacek JA
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920733
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Should next-generation sequencing testing be routinely used in metastatic colorectal cancer?
    Dienstmann R; Ciner A; Hochster HS
    Lancet Oncol; 2018 Nov; 19(11):1434-1435. PubMed ID: 30507475
    [No Abstract]   [Full Text] [Related]  

  • 49. Prospective Cardiovascular Genetics Evaluation in Spontaneous Coronary Artery Dissection.
    Kaadan MI; MacDonald C; Ponzini F; Duran J; Newell K; Pitler L; Lin A; Weinberg I; Wood MJ; Lindsay ME
    Circ Genom Precis Med; 2018 Apr; 11(4):e001933. PubMed ID: 29650765
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene-based medicine: the new frontier.
    Drown DJ
    Prog Cardiovasc Nurs; 2001; 16(1):37-8. PubMed ID: 11252878
    [No Abstract]   [Full Text] [Related]  

  • 51. Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer-an European consensus statement and expert recommendations.
    Singer CF; Balmaña J; Bürki N; Delaloge S; Filieri ME; Gerdes AM; Grindedal EM; Han S; Johansson O; Kaufman B; Krajc M; Loman N; Olah E; Paluch-Shimon S; Plavetic ND; Pohlodek K; Rhiem K; Teixeira M; Evans DG
    Eur J Cancer; 2019 Jan; 106():54-60. PubMed ID: 30471648
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is There a Role for Genetics in the Prevention of Sudden Cardiac Death?
    Faragli A; Underwood K; Priori SG; Mazzanti A
    J Cardiovasc Electrophysiol; 2016 Sep; 27(9):1124-32. PubMed ID: 27279603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetics and cardiovascular disease.
    Acton RT; Go RC; Roseman JM
    Ethn Dis; 2004; 14(4):S2-8-16. PubMed ID: 15724791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The value of cardiac genetic testing.
    Ingles J; Semsarian C
    Trends Cardiovasc Med; 2014 Aug; 24(6):217-24. PubMed ID: 25066489
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gastric cancer and family history.
    Choi YJ; Kim N
    Korean J Intern Med; 2016 Nov; 31(6):1042-1053. PubMed ID: 27809451
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetics of CVD in 2017: Expanding the spectrum of CVD genetics.
    Schunkert H
    Nat Rev Cardiol; 2018 Feb; 15(2):77-78. PubMed ID: 29263443
    [No Abstract]   [Full Text] [Related]  

  • 57. A 45-SNP genetic risk score is increased in early-onset coronary artery disease but independent of familial disease clustering.
    Christiansen MK; Nyegaard M; Pedersen LN; Larsen SB; Würtz M; Hjort J; Kristensen SD; Jensen HK
    Atherosclerosis; 2017 Feb; 257():172-178. PubMed ID: 28142076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Screening in GI Cancers: The Role of Genetics.
    Stoffel EM
    J Clin Oncol; 2015 Jun; 33(16):1721-8. PubMed ID: 25918283
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Strengths and Opportunities of Network Medicine in Cardiovascular Diseases.
    Benincasa G; Marfella R; Della Mura N; Schiano C; Napoli C
    Circ J; 2020 Jan; 84(2):144-152. PubMed ID: 31866635
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluid-based assays and precision medicine of cardiovascular diseases: the 'hope' for Pandora's box?
    Benincasa G; Mansueto G; Napoli C
    J Clin Pathol; 2019 Dec; 72(12):785-799. PubMed ID: 31611285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.